Optipharm.CO.,LTD
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
153710 | KO
Overview
Corporate Details
- ISIN(s):
- KR7153710009
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청주시 흥덕구 오송읍 오송생명6로 63, 청주시
- Website:
- https://www.optipharm.co.kr
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Optipharm.CO.,LTD is a biotechnology company specializing in animal health and advanced biomedical solutions. The company's core activities include animal disease diagnosis, the development of veterinary pharmaceuticals, bacteriophage-based products, and Virus-Like Particle (VLP) vaccines. A key focus for Optipharm is xenotransplantation, where it conducts pioneering research and development of genetically engineered pigs for organ transplantation to address human organ shortages. The company has achieved significant milestones in preclinical trials, including record survival times for primates that have received transplanted organs, positioning it at the forefront of regenerative medicine and organ transplant technology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-03 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.3 MB | ||
| 2025-07-31 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.8 KB | ||
| 2025-06-30 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 27.4 KB | ||
| 2025-06-10 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.9 KB | ||
| 2025-05-19 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 26.6 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.3 MB | ||
| 2025-05-02 00:00 |
Regulatory News Service
[기재정정]투자판단관련주요경영사항 (민군겸용 기술개발사업(형질전환돼지 기반 수혈가능 이종적혈구제제 기술개발) 국책과제 …
|
Korean | 23.4 KB | ||
| 2025-04-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 26.6 KB | ||
| 2025-03-24 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 23.2 KB | ||
| 2025-03-20 00:00 |
Regulatory News Service
[기재정정]신규시설투자등
|
Korean | 11.4 KB | ||
| 2025-03-14 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 17.7 KB | ||
| 2025-03-14 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 1.5 MB | ||
| 2025-03-07 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 12.6 KB | ||
| 2025-03-07 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 154.7 KB |
Automate Your Workflow. Get a real-time feed of all Optipharm.CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Optipharm.CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Optipharm.CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
